MedTrace Logo

Inflammatory Cytokine Quantification in Infants

NCT01155830 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2015-05-04

Study results available
· View outcomes & findings →

Summary

This study proposes to quantify inflammatory cytokine profiles in three neonatal disease states, namely, neonatal sepsis, infants with a congenital diaphragmatic hernia defect, and infants suffering cardiopulmonary failure significant enough to require heart/lung bypass treatment with extracorporeal membrane oxygenation (ECMO).

Conditions

  • Sepsis
  • Congenital Diaphragmatic Hernia
  • Neonatal Cardiopulmonary Failure

Sponsors & Collaborators

Principal Investigators

  • Donald Null, MD · University of Utah

Eligibility

Max Age
2 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2013-05-31
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01155830 on ClinicalTrials.gov